Point-of-care Testing (poct) Market in Us 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	146 Pages	TechNavio	August, 2024	INF19175998

Best Price Guarantee
Price	from $2,500
Length	146 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19175998

Point-Of-Care Testing (POCT) Market In US 2024-2028

The point-of-care testing (POCT) market in US is forecasted to grow by USD 10216.7 mn during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the point-of-care testing (POCT) market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, rising awareness regarding portable and low-cost self-testing devices, and rising number of clia-waived POCT.

Technavio's point-of-care testing (POCT) market in US is segmented as below:

By Type

OTC testing
Prescription-based testing

By Application

Blood glucose testing
Infectious diseases testing
Cardiac markers testing
Pregnancy and fertility testing
Others

By Geographical Landscape

North America

This study identifies the technological advancements in POCT devices as one of the prime reasons driving the point-of-care testing (POCT) market in US growth during the next few years. Also, rise in adoption of personalized medicine and POCT with multiplexing capabilities will lead to sizable demand in the market.

The report on the point-of-care testing (POCT) market in US covers the following areas:

Point-of-care testing (POCT) market in US sizing
Point-of-care testing (POCT) market in US forecast
Point-of-care testing (POCT) market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point-of-care testing (POCT) market in US vendors that include Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., Boditech Med Inc., Cardinal Health Inc., Chembio Diagnostics Inc., Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Heska Corp., iAssay Inc., Johnson and Johnson Services Inc., Nova Biomedical Corp., OraSure Technologies Inc., Phamatech Inc., Princeton BioMeditech Corp., Quest Diagnostics Inc., QuidelOrtho Corp., Sekisui Chemical Co. Ltd., Trivida Health Inc., and Zoetis Inc.. Also, the point-of-care testing (POCT) market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US: Year-over-year growth 2023-2028 (%); Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Point-Of-Care Testing (POCT) Market in US 2018 - 2022; Historic Market Size - Data Table on Point-Of-Care Testing (POCT) Market in US 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 OTC testing - Market size and forecast 2023-2028; Chart on OTC testing - Market size and forecast 2023-2028 ($ million); Data Table on OTC testing - Market size and forecast 2023-2028 ($ million); Chart on OTC testing - Year-over-year growth 2023-2028 (%); Data Table on OTC testing - Year-over-year growth 2023-2028 (%); 6.4 Prescription-based testing - Market size and forecast 2023-2028; Chart on Prescription-based testing - Market size and forecast 2023-2028 ($ million); Data Table on Prescription-based testing - Market size and forecast 2023-2028 ($ million); Chart on Prescription-based testing - Year-over-year growth 2023-2028 (%); Data Table on Prescription-based testing - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Blood glucose testing - Market size and forecast 2023-2028; Chart on Blood glucose testing - Market size and forecast 2023-2028 ($ million); Data Table on Blood glucose testing - Market size and forecast 2023-2028 ($ million); Chart on Blood glucose testing - Year-over-year growth 2023-2028 (%); Data Table on Blood glucose testing - Year-over-year growth 2023-2028 (%); 7.4 Infectious diseases testing - Market size and forecast 2023-2028; Chart on Infectious diseases testing - Market size and forecast 2023-2028 ($ million); Data Table on Infectious diseases testing - Market size and forecast 2023-2028 ($ million); Chart on Infectious diseases testing - Year-over-year growth 2023-2028 (%); Data Table on Infectious diseases testing - Year-over-year growth 2023-2028 (%); 7.5 Cardiac markers testing - Market size and forecast 2023-2028; Chart on Cardiac markers testing - Market size and forecast 2023-2028 ($ million); Data Table on Cardiac markers testing - Market size and forecast 2023-2028 ($ million); Chart on Cardiac markers testing - Year-over-year growth 2023-2028 (%); Data Table on Cardiac markers testing - Year-over-year growth 2023-2028 (%); 7.6 Pregnancy and fertility testing - Market size and forecast 2023-2028; Chart on Pregnancy and fertility testing - Market size and forecast 2023-2028 ($ million); Data Table on Pregnancy and fertility testing - Market size and forecast 2023-2028 ($ million); Chart on Pregnancy and fertility testing - Year-over-year growth 2023-2028 (%); Data Table on Pregnancy and fertility testing - Year-over-year growth 2023-2028 (%); 7.7 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 11.4 ACON Laboratories Inc.; ACON Laboratories Inc. - Overview; ACON Laboratories Inc. - Product / Service; ACON Laboratories Inc. - Key offerings; 11.5 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; 11.6 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; 11.7 Cardinal Health Inc.; Cardinal Health Inc. - Overview; Cardinal Health Inc. - Business segments; Cardinal Health Inc. - Key news; Cardinal Health Inc. - Key offerings; Cardinal Health Inc. - Segment focus; 11.8 Chembio Diagnostics Inc.; Chembio Diagnostics Inc. - Overview; Chembio Diagnostics Inc. - Product / Service; Chembio Diagnostics Inc. - Key news; Chembio Diagnostics Inc. - Key offerings; 11.9 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; 11.10 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 11.11 Nova Biomedical Corp.; Nova Biomedical Corp. - Overview; Nova Biomedical Corp. - Product / Service; Nova Biomedical Corp. - Key offerings; 11.12 OraSure Technologies Inc.; OraSure Technologies Inc. - Overview; OraSure Technologies Inc. - Business segments; OraSure Technologies Inc. - Key news; OraSure Technologies Inc. - Key offerings; OraSure Technologies Inc. - Segment focus; 11.13 Princeton BioMeditech Corp.; Princeton BioMeditech Corp. - Overview; Princeton BioMeditech Corp. - Product / Service; Princeton BioMeditech Corp. - Key offerings; 11.14 Quest Diagnostics Inc.; Quest Diagnostics Inc. - Overview; Quest Diagnostics Inc. - Business segments; Quest Diagnostics Inc. - Key offerings; Quest Diagnostics Inc. - Segment focus; 11.15 QuidelOrtho Corp.; QuidelOrtho Corp. - Overview; QuidelOrtho Corp. - Product / Service; QuidelOrtho Corp. - Key offerings; 11.16 Trivida Health Inc.; Trivida Health Inc. - Overview; Trivida Health Inc. - Product / Service; Trivida Health Inc. - Key offerings; 11.17 Zoetis Inc.; Zoetis Inc. - Overview; Zoetis Inc. - Business segments; Zoetis Inc. - Key news; Zoetis Inc. - Key offerings; Zoetis Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 12.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Company Market Positioning; Exhibits7: Parent Market; Exhibits8: Data Table on - Parent Market; Exhibits9: Market characteristics analysis; Exhibits10: Value Chain Analysis; Exhibits11: Offerings of companies included in the market definition; Exhibits12: Market segments; Exhibits13: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits14: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits15: Chart on US: Year-over-year growth 2023-2028 (%); Exhibits16: Data Table on US: Year-over-year growth 2023-2028 (%); Exhibits17: Historic Market Size - Data Table on Point-Of-Care Testing (POCT) Market in US 2018 - 2022 ($ million); Exhibits18: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on Type - Market share 2023-2028 (%); Exhibits28: Data Table on Type - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by Type; Exhibits30: Data Table on Comparison by Type; Exhibits31: Chart on OTC testing - Market size and forecast 2023-2028 ($ million); Exhibits32: Data Table on OTC testing - Market size and forecast 2023-2028 ($ million); Exhibits33: Chart on OTC testing - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on OTC testing - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Prescription-based testing - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Prescription-based testing - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Prescription-based testing - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Prescription-based testing - Year-over-year growth 2023-2028 (%); Exhibits39: Market opportunity by Type ($ million); Exhibits40: Data Table on Market opportunity by Type ($ million); Exhibits41: Chart on Application - Market share 2023-2028 (%); Exhibits42: Data Table on Application - Market share 2023-2028 (%); Exhibits43: Chart on Comparison by Application; Exhibits44: Data Table on Comparison by Application; Exhibits45: Chart on Blood glucose testing - Market size and forecast 2023-2028 ($ million); Exhibits46: Data Table on Blood glucose testing - Market size and forecast 2023-2028 ($ million); Exhibits47: Chart on Blood glucose testing - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Blood glucose testing - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Infectious diseases testing - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Infectious diseases testing - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Infectious diseases testing - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Infectious diseases testing - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Cardiac markers testing - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Cardiac markers testing - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Cardiac markers testing - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Cardiac markers testing - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Pregnancy and fertility testing - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Pregnancy and fertility testing - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Pregnancy and fertility testing - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Pregnancy and fertility testing - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Market opportunity by Application ($ million); Exhibits66: Data Table on Market opportunity by Application ($ million); Exhibits67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits68: Impact of drivers and challenges in 2023 and 2028; Exhibits69: Overview on criticality of inputs and factors of differentiation; Exhibits70: Overview on factors of disruption; Exhibits71: Impact of key risks on business; Exhibits72: Companies covered; Exhibits73: Matrix on companies position and classification; Exhibits74: Abbott Laboratories - Overview; Exhibits75: Abbott Laboratories - Business segments; Exhibits76: Abbott Laboratories - Key news; Exhibits77: Abbott Laboratories - Key offerings; Exhibits78: Abbott Laboratories - Segment focus; Exhibits79: ACON Laboratories Inc. - Overview; Exhibits80: ACON Laboratories Inc. - Product / Service; Exhibits81: ACON Laboratories Inc. - Key offerings; Exhibits82: Becton Dickinson and Co. - Overview; Exhibits83: Becton Dickinson and Co. - Business segments; Exhibits84: Becton Dickinson and Co. - Key news; Exhibits85: Becton Dickinson and Co. - Key offerings; Exhibits86: Becton Dickinson and Co. - Segment focus; Exhibits87: Bio Rad Laboratories Inc. - Overview; Exhibits88: Bio Rad Laboratories Inc. - Business segments; Exhibits89: Bio Rad Laboratories Inc. - Key news; Exhibits90: Bio Rad Laboratories Inc. - Key offerings; Exhibits91: Bio Rad Laboratories Inc. - Segment focus; Exhibits92: Cardinal Health Inc. - Overview; Exhibits93: Cardinal Health Inc. - Business segments; Exhibits94: Cardinal Health Inc. - Key news; Exhibits95: Cardinal Health Inc. - Key offerings; Exhibits96: Cardinal Health Inc. - Segment focus; Exhibits97: Chembio Diagnostics Inc. - Overview; Exhibits98: Chembio Diagnostics Inc. - Product / Service; Exhibits99: Chembio Diagnostics Inc. - Key news; Exhibits100: Chembio Diagnostics Inc. - Key offerings; Exhibits101: Danaher Corp. - Overview; Exhibits102: Danaher Corp. - Business segments; Exhibits103: Danaher Corp. - Key news; Exhibits104: Danaher Corp. - Key offerings; Exhibits105: Danaher Corp. - Segment focus; Exhibits106: Johnson and Johnson Services Inc. - Overview; Exhibits107: Johnson and Johnson Services Inc. - Business segments; Exhibits108: Johnson and Johnson Services Inc. - Key news; Exhibits109: Johnson and Johnson Services Inc. - Key offerings; Exhibits110: Johnson and Johnson Services Inc. - Segment focus; Exhibits111: Nova Biomedical Corp. - Overview; Exhibits112: Nova Biomedical Corp. - Product / Service; Exhibits113: Nova Biomedical Corp. - Key offerings; Exhibits114: OraSure Technologies Inc. - Overview; Exhibits115: OraSure Technologies Inc. - Business segments; Exhibits116: OraSure Technologies Inc. - Key news; Exhibits117: OraSure Technologies Inc. - Key offerings; Exhibits118: OraSure Technologies Inc. - Segment focus; Exhibits119: Princeton BioMeditech Corp. - Overview; Exhibits120: Princeton BioMeditech Corp. - Product / Service; Exhibits121: Princeton BioMeditech Corp. - Key offerings; Exhibits122: Quest Diagnostics Inc. - Overview; Exhibits123: Quest Diagnostics Inc. - Business segments; Exhibits124: Quest Diagnostics Inc. - Key offerings; Exhibits125: Quest Diagnostics Inc. - Segment focus; Exhibits126: QuidelOrtho Corp. - Overview; Exhibits127: QuidelOrtho Corp. - Product / Service; Exhibits128: QuidelOrtho Corp. - Key offerings; Exhibits129: Trivida Health Inc. - Overview; Exhibits130: Trivida Health Inc. - Product / Service; Exhibits131: Trivida Health Inc. - Key offerings; Exhibits132: Zoetis Inc. - Overview; Exhibits133: Zoetis Inc. - Business segments; Exhibits134: Zoetis Inc. - Key news; Exhibits135: Zoetis Inc. - Key offerings; Exhibits136: Zoetis Inc. - Segment focus; Exhibits137: Inclusions checklist; Exhibits138: Exclusions checklist; Exhibits139: Currency conversion rates for US$; Exhibits140: Research methodology; Exhibits141: Information sources; Exhibits142: Data validation; Exhibits143: Validation techniques employed for market sizing; Exhibits144: Data synthesis; Exhibits145: 360 degree market analysis; Exhibits146: List of abbreviations